CONHealthcare · Medical Care FacilitiesThe 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. hold a median 12-month price target of $41 — +8.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 96 of 100 as at 14 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Concentra Group Holdings Parent, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (99): Analysts have, on balance, been raising their forecasts.
Accruals (57): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (23): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CON, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +8.1% from it.
Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 10 Sept 2026 | JP Morgan | Maintains | Overweight | $34 → $43 |
| 11 Aug 2026 | Wells Fargo | Maintains | Overweight | — |
| 11 Aug 2026 | Wells Fargo | Maintains | Overweight | $28 → $40 |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | — |
| 10 Aug 2026 | RBC Capital | Maintains | Outperform | $36 → $42 |
| 10 Aug 2026 | Truist Securities | Maintains | Buy | $37 → $42 |
| 10 Aug 2026 | Truist Securities | Maintains | Buy | — |
| 14 July 2026 | Truist Securities | Maintains | Buy | $31 → $37 |
| 14 July 2026 | Truist Securities | Maintains | Buy | — |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 1 July 2026 | William Blair | Initiates | Outperform | — |
| 5 June 2026 | Goldman Sachs | Initiates | Buy | — |
| 11 May 2026 | Truist Securities | Reiterates | Buy | — |
| 5 Mar 2026 | Wells Fargo | Maintains | Overweight | — |
| 2 Feb 2026 | RBC Capital | Maintains | Outperform | — |
| 18 Sept 2025 | JP Morgan | Assumes | Overweight | $31 |
| 19 Mar 2025 | JP Morgan | Maintains | Overweight | — |
| 12 Mar 2025 | Wells Fargo | Maintains | Overweight | — |
| 23 Jan 2025 | B of A Securities | Maintains | Buy | — |
| 23 Jan 2025 | RBC Capital | Reiterates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CON appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Concentra Group Holdings Parent, Inc. returned +87.0% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 31% of US stocks
Cheaper than 51% of US stocks
Cheaper than 9% of US stocks
Cheaper than 23% of US stocks
Higher than 52% of US stocks
Higher than 73% of US stocks
Higher than 36% of US stocks
Higher than 78% of US stocks
Higher than 67% of US stocks
Higher than 93% of US stocks
Higher than 88% of US stocks
Higher than 67% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Concentra Group Holdings Parent, Inc. has a market value of $4.8B and an enterprise value of $6.8B.
Revenue in the twelve months to 30 June 2026: $2.3B. The latest quarter grew 10.0% year on year.
Net income over the same four quarters: $205.6M, a 9.0% net margin.
Diluted earnings per share, trailing twelve months: $1.55.
Free cash flow in the twelve months to 30 June 2026: $267.4M.
Concentra Group Holdings Parent, Inc. spent $32.1M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 24.2×; forward P/E: 20.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.67%, paying out 16% of earnings.
Concentra Group Holdings Parent, Inc. employs 9,967 people — $230K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Concentra Group Holdings Parent, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research compares Concentra Group (CON) and Medpace (MEDP) for investors seeking value among medical services stocks, asking which may offer better value.
Why it matters — The item directly compares CON with MEDP from a value-investing perspective, which may interest investors following CON.
Concentra said it will report third-quarter 2026 financial results after the market closes on November 5, 2026. It will host a live webcast conference call about the results on November 6 at 9 a.m. Eastern Time.
Why it matters — CON watchers can note the scheduled date and time for the company’s results release and conference call.
Concentra Group Holdings Parent, Inc. (CON) reached a 52-week high. The article says it examines the company's fundamentals for clues about whether further gains may follow.
Why it matters — CON watchers may find the company's fundamentals relevant when assessing the context around its 52-week high.
MarketBeat reports that Concentra's healthcare business is growing, widening its margins, paying down debt, and paying a dividend simultaneously. Wall Street has assigned the stock a full Buy rating and sees further upside ahead.
Why it matters — A CON watcher would care because the report highlights simultaneous growth, margin expansion, debt reduction, and shareholder returns, all of which contributed to a positive analyst assessment of the stock.
Zacks Investment Research published a comparison of Concentra Group (CON) and Medpace (MEDP), both Medical Services stocks, to determine which offers value investors a better opportunity. The article frames the two as competing options for value-focused investors.
Why it matters — CON watchers would care because the piece positions Concentra against a direct peer in the Medical Services sector, offering a comparative value assessment that could influence how investors view CON.
The 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. have a median 12-month price target of $41, with estimates ranging from $40 to $43. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Concentra Group Holdings Parent, Inc., 9 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Concentra Group Holdings Parent, Inc. 96 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, Concentra Group Holdings Parent, Inc. ranks 96 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (99 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +8.1% from the last close, and Ticker Nerd's factor model ranks Concentra Group Holdings Parent, Inc. 96 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Concentra Group Holdings Parent, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CON are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $40 to $43 over the next 12 months.
Concentra Group Holdings Parent, Inc. returned +87.0% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States.
The most recent item we track (Zacks Investment Research, 14 Oct 2026): "CON vs. MEDP: Which Stock Should Value Investors Buy Now?". Zacks Investment Research compares Concentra Group (CON) and Medpace (MEDP) for investors seeking value among medical services stocks, asking which may offer better value.
Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States. It provides workplace-oriented medical care through occupational health centers, onsite health clinics, and complementary service lines designed to support employers and working populations. Its offerings include workers’ compensation injury care, urgent care, clinical testing, preventive care, employer-sponsored primary care, telemedicine for work-related injuries and illnesses, pharmacy services, and medical compliance administration. Concentra Group Holdings Parent, Inc. serves businesses across industries that rely on employee health and safety programs, helping manage care delivered at employer worksites and through its network of health centers. The company is headquartered in Addison, Texas.
CEO Mr. William Keith Newton · 9,967 employees · United States · https://www.concentra.com
